| The central and biodynamic role of gut microbiota in critically ill patients H Wozniak, TS Beckmann, L Fröhlich, T Soccorsi, C Le Terrier, ... Critical Care 26 (1), 250, 2022 | 36 | 2022 |
| Blood transfusion reactions—a comprehensive review of the literature including a swiss perspective T Ackfeld, T Schmutz, Y Guechi, C Le Terrier Journal of Clinical Medicine 11 (10), 2859, 2022 | 36 | 2022 |
| Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: an emulated target trial analysis D Hajage, A Combes, C Guervilly, G Lebreton, A Mercat, A Pavot, S Nseir, ... American journal of respiratory and critical care medicine 206 (3), 281-294, 2022 | 33 | 2022 |
| Preparedness and reorganization of care for coronavirus disease 2019 patients in a Swiss ICU: characteristics and outcomes of 129 patients S Primmaz, C Le Terrier, N Suh, F Ventura, F Boroli, K Bendjelid, ... Critical care explorations 2 (8), e0173, 2020 | 31 | 2020 |
| Impact of a restrictive antibiotic policy on the acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae in an endemic region: a before-and-after … C Le Terrier, M Vinetti, P Bonjean, R Richard, B Jarrige, B Pons, ... Critical Care 25, 1-12, 2021 | 24 | 2021 |
| Prevalence of anxiety and depression symptomatology in adolescents faced with the hospitalization of a loved one in the ICU JL Fergé, C Le Terrier, R Banydeen, N Kentish-Barnes, C Derancourt, ... Critical care medicine 46 (4), e330-e333, 2018 | 23 | 2018 |
| NDM-9 resistance to taniborbactam C Le Terrier, V Gruenig, C Fournier, P Nordmann, L Poirel The Lancet Infectious Diseases 23 (4), 401-402, 2023 | 21 | 2023 |
| In vitro activity of cefepime/zidebactam and cefepime/taniborbactam against aztreonam/avibactam-resistant NDM-like-producing Escherichia coli clinical isolates C Le Terrier, P Nordmann, M Sadek, L Poirel Journal of Antimicrobial Chemotherapy 78 (5), 1191-1194, 2023 | 20 | 2023 |
| In vitro activity of aztreonam in combination with newly developed β-lactamase inhibitors against MDR Enterobacterales and Pseudomonas aeruginosa producing … C Le Terrier, P Nordmann, L Poirel Journal of Antimicrobial Chemotherapy 78 (1), 101-107, 2023 | 18 | 2023 |
| Delayed intubation is associated with mortality in patients with severe COVID-19: A single-centre observational study in Switzerland C Le Terrier, N Suh, H Wozniak, F Boroli, A Giudicelli-Bailly, F Sangla, ... Anaesthesia Critical Care & Pain Medicine 41 (4), 101092, 2022 | 16 | 2022 |
| Early prone positioning in acute respiratory distress syndrome related to COVID-19: a propensity score analysis from the multicentric cohort COVID-ICU network—the ProneCOVID study C Le Terrier, F Sigaud, S Lebbah, L Desmedt, D Hajage, C Guérin, ... Critical Care 26 (1), 71, 2022 | 16 | 2022 |
| Wide spread of carbapenemase-producing bacterial isolates in a Nigerian environment C Le Terrier, A Masseron, NS Uwaezuoke, CP Edwin, AE Ekuma, ... Journal of global antimicrobial resistance 21, 321-323, 2020 | 15 | 2020 |
| Early measurement of ROX index in intermediary care unit is associated with mortality in intubated COVID-19 patients: a retrospective study A Leszek, H Wozniak, A Giudicelli-Bailly, N Suh, F Boroli, J Pugin, ... Journal of Clinical Medicine 11 (2), 365, 2022 | 14 | 2022 |
| Impact of acquired broad spectrum β-lactamases on susceptibility to novel combinations made of β-lactams (aztreonam, cefepime, meropenem, and imipenem) and novel β-lactamase … C Le Terrier, P Nordmann, C Freret, M Seigneur, L Poirel Antimicrobial Agents and Chemotherapy 67 (7), e00339-23, 2023 | 12 | 2023 |
| Mental health of adolescent relatives of intensive care patients: benefits of an open visitation policy JL Fergé, R Banydeen, C Le Terrier, H Fize, M Miguel, N Kentish-Barnes, ... American Journal of Critical Care 30 (1), 72-76, 2021 | 12 | 2021 |
| Wide dissemination of gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant: a one health concern C Le Terrier, P Nordmann, C Buchs, DYW Di, GM Rossolini, R Stephan, ... Journal of Antimicrobial Chemotherapy 78 (9), 2382-2384, 2023 | 10 | 2023 |
| Impact of nutritional therapy during the first wave of the COVID-19 pandemic in intensive care patients: A retrospective observational study A de Watteville, F Montalbano, H Wozniak, TH Collet, C Jaksic, ... Clinical Nutrition 41 (12), 3016-3021, 2022 | 10 | 2022 |
| SARS‐CoV‐2 infection as a trigger of humoral response against apolipoprotein A‐1 S Pagano, S Yerly, B Meyer, C Juillard, N Suh, C Le Terrier, JP Daguer, ... European Journal of Clinical Investigation 51 (11), e13661, 2021 | 9 | 2021 |
| Limitation of life-sustaining therapies in critically ill patients with COVID-19: a descriptive epidemiological investigation from the COVID-ICU study M Giabicani, C Le Terrier, A Poncet, B Guidet, JP Rigaud, JP Quenot, ... Critical Care 27 (1), 103, 2023 | 6 | 2023 |
| Structural basis of metallo-β-lactamase resistance to taniborbactam SI Drusin, C Le Terrier, L Poirel, RA Bonomo, AJ Vila, DM Moreno Antimicrobial Agents and Chemotherapy 68 (2), e01168-23, 2024 | 4 | 2024 |
